… ·7), but the risk of myocardial infarction was not increased (0·9, 0·5– 1·6). Neither aCL nor
antiprothrombin antibodies affected the risk of myocardial infarction or ischaemic stroke. There …

… In a large population study of women younger than 50 years admitted with first ischemic
stroke or myocardial infarction (MI), LA was tested positive in 17% of patients with stroke and 3% …

… and warfarin, acute myocardial infarction has been documented in … myocardial infarction in
patients with anticardiolipin antibodies, a study published in 1989 noted myocardial infarction …

… Antiphospholipid syndrome (APS) is an autoimmune coagulation disorder that manifests as
recurrent venous or arterial thrombosis. High levels of antiphospholipid … myocardial infarction…

… In addition, APS patients were compared to 1,458 patients with ST segment elevation
myocardial infarction (MI) who were treated with PCI during the same period. Sixmonth to 4-year …

… Antiphospholipid syndrome is an autoimmune disorder that … anterolateral ST elevation
myocardial infarction and large left … He was later diagnosed with antiphospholipid syndrome. …

… therapy in myocardial infarction that was due to the antiphospholipid antibody syndrome. We
… treatment modalities in acute thrombotic events in the antiphospholipid antibody syndrome. …

… Thrombosis subsets include: venous (usually deep vein thrombosis or pulmonary emboli);
arterial (usually stroke or myocardial infarction); and microvascular (which would include …

… Antiphospholipid syndrome is a disorder characterized by arterial or venous thrombosis, high
plasma levels of antiphospholipid … presented with ST elevation myocardial infarction (MI) …

… APS is an important cause of myocardial infarction with non-obstructive CAD (MINOCA) and/…
cardiac events, repeated revascularization and myocardial infarction during 1-year follow up …